{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T16:40:48Z","timestamp":1719074448625},"reference-count":66,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.gastrohep.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T18:30:15Z","timestamp":1487701815000},"page":"447-454","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["An optimized clarithromycin-free 14-day triple therapy for Helicobacter pylori eradication achieves high cure rates in Uruguay"],"prefix":"10.1016","volume":"40","author":[{"given":"Cristina","family":"Dacoll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"S\u00e1nchez-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henia","family":"Balter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximena","family":"Pazos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Di Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Sandoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2017.01.002_bib0335","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MCG.0b013e31829f2e25","article-title":"Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia","volume":"48","author":"Zhao","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0340","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-07-167155","article-title":"Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review","volume":"113","author":"Stasi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0345","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ijc.24290","article-title":"Recent patterns in gastric cancer: a global overview","volume":"125","author":"Bertuccio","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0350","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0355","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0889-8553(21)00271-5","article-title":"Treatment strategies for Helicobacter pylori infection","volume":"22","author":"Marshall","year":"1993","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0360","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection \u2013 the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0365","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MCG.0b013e31820fb8f6","article-title":"World Gastroenterology Organisation Global Guideline: Helicobacter pylori in developing countries","volume":"45","author":"World Gastroenterology Organisation","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0370","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/j.1572-0241.2000.03174.x","article-title":"Latin-American Consensus Conference on Helicobacter pylori infection","volume":"95","author":"Coelho","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0375","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(11)60825-8","article-title":"14-Day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial","volume":"378","author":"Greenberg","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0380","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0385","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","article-title":"Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial","volume":"377","author":"Malfertheiner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0390","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0395","doi-asserted-by":"crossref","first-page":"10969","DOI":"10.3748\/wjg.v20.i31.10969","article-title":"Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus","volume":"20","author":"Rollan","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0400","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/jama.2013.311","article-title":"Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities","volume":"309","author":"Morgan","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0405","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.35.5.869","article-title":"Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells","volume":"35","author":"Megraud","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0410","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.gtc.2006.03.004","article-title":"Helicobacter pylori diagnosis and management","volume":"35","author":"Vilaichone","year":"2006","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0415","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2036.2000.00770.x","article-title":"Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study","volume":"14","author":"Graham","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0420","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2000.00744.x","article-title":"A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection","volume":"14","author":"Calvet","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0425","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-147-8-200710160-00008","article-title":"Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication","volume":"147","author":"Fuccio","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0430","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2036.2008.03807.x","article-title":"Meta-analysis: high-dose proton pump inhibitors versus standard dose in triple therapy for Helicobacter pylori eradication","volume":"28","author":"Villoria","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0435","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2036.2012.05137.x","article-title":"High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates","volume":"36","author":"S\u00e1nchez-Delgado","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0440","first-page":"88","article-title":"[Evolution of the response to the first-line therapy for Helicobacter pylori infection in Uruguay]","volume":"44","author":"Dacoll","year":"2014","journal-title":"Acta Gastroenterol Latinoam"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0445","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1523-5378.2012.00947.x","article-title":"Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains","volume":"17","author":"Molina-Infante","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0450","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.03.050","article-title":"Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori Infection in populations with high rates of antibiotic resistance","volume":"145","author":"Molina-Infante","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0455","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/apt.13069","article-title":"Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study","volume":"41","author":"Molina-Infante","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0460","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1523-5378.1996.tb00027.x","article-title":"Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study","volume":"1","author":"Lind","year":"1996","journal-title":"Helicobacter"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0465","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00045391-199901000-00005","article-title":"Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta-regression analysis of randomized, controlled trials","volume":"6","author":"Schmid","year":"1999","journal-title":"Am J Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0470","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/ajg.2014.24","article-title":"The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America","volume":"109","author":"Camargo","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0475","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1093\/jac\/dkw220","article-title":"Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment","volume":"71","author":"Puig","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0480","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.43.11.2747","article-title":"Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study","volume":"43","author":"M\u00e9graud","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8579(01)00468-X","article-title":"Metronidazole resistance in Helicobacter pylori","volume":"19","author":"Jenks","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0490","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0016-5085(98)70633-X","article-title":"The role of internal urease in acid resistance of Helicobacter pylori","volume":"114","author":"Scott","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0495","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1523-5378.2007.00508.x","article-title":"Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy","volume":"12","author":"Sugimoto","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0500","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00228-008-0576-5","article-title":"Relative potency of proton-pump inhibitors \u2013 comparison of effects on intragastric pH","volume":"65","author":"Kirchheiner","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0505","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/ajg.2016.443","article-title":"Rescue therapy for Helicobacter pylori eradication: a randomized non-inferiority trial of amoxicillin or tetracycline in bismuth quadruple therapy","volume":"111","author":"Chen","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0510","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gutjnl-2015-311019","article-title":"Role of bismuth in improving Helicobacter pylori eradication with triple therapy","volume":"65","author":"Dore","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0515","first-page":"145","article-title":"[The role of tetracycline in the retreatment after Helicobacter pylori eradication failure]","volume":"92","author":"Auriemma","year":"2001","journal-title":"Minerva Med"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0520","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1046\/j.1365-2036.1999.00606.x","article-title":"Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection","volume":"13","author":"Bayerd\u00f6rffer","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0525","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-230X-1-7","article-title":"Efficacy of Helicobacter pylori eradication therapies: a single centre observational study","volume":"1","author":"Beales","year":"2001","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0530","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2036.1995.tb00349.x","article-title":"Rapid eradication of Helicobacter pylori infection","volume":"9","author":"Bell","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0535","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1590-8658(00)80395-3","article-title":"Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study)","volume":"32","author":"Di Mario","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0540","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00042737-200106000-00012","article-title":"The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori","volume":"13","author":"Ell","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0545","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1523-5378.2009.00656.x","article-title":"Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens","volume":"14","author":"Filipec Kanizaj","year":"2009","journal-title":"Helicobacter"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0550","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00228-010-0818-1","article-title":"Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole","volume":"66","author":"Gawro\u0144ska-Szklarz","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0555","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2036.1998.00362.x","article-title":"Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group","volume":"12","author":"Harris","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0560","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2036.1995.tb00350.x","article-title":"Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen","volume":"9","author":"Hudson","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0565","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1046\/j.1365-2036.2002.01384.x","article-title":"One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese","volume":"16","author":"Hung","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0570","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1365-2036.2000.00776.x","article-title":"Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study","volume":"14","author":"Katelaris","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0575","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1365-2036.2005.02398.x","article-title":"First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens","volume":"21","author":"Koivisto","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0580","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00228-006-0183-2","article-title":"Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients","volume":"62","author":"Kurzawski","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0585","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1046\/j.1365-2036.2003.01560.x","article-title":"Helicobacter pylori eradication and gastric ulcer healing \u2013 comparison of three pantoprazole-based triple therapies","volume":"17","author":"Malfertheiner","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0590","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/gut.41.6.735","article-title":"One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group","volume":"41","author":"Misiewicz","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0595","doi-asserted-by":"crossref","DOI":"10.2478\/v10039-008-0043-7","article-title":"Smoking and drinking habits are important predictors of Helicobacter pylori eradication","volume":"53","author":"Namiot","year":"2008","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0600","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2710.2002.00428.x","article-title":"Quantification of Helicobacter pylori resistance in functional and organic dyspepsia","volume":"27","author":"Rosandi\u0107","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0605","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2036.1999.00522.x","article-title":"Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori","volume":"13","author":"Savarino","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0610","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2036.1997.155329000.x","article-title":"One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance","volume":"11","author":"Thijs","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0615","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2036.2000.00689.x","article-title":"Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study","volume":"14","author":"Wong","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0620","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/00365520310008674","article-title":"Does the \u201ctest-and-treat\u201d strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients","volume":"39","author":"F\u00e4rkkil\u00e4","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0625","first-page":"248","article-title":"Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?","volume":"92","author":"Lerang","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0630","first-page":"225","article-title":"[Azithromycin versus amoxicillin in triple therapy for the treatment of Helicobacter pylori infection]","volume":"44","author":"Mezzi","year":"1998","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0635","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/00365529409105357","article-title":"Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients","volume":"201","author":"Solcia","year":"1994","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0640","first-page":"790","article-title":"Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?","volume":"92","author":"Annibale","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0645","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1440-1746.2003.03276.x","article-title":"Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity","volume":"19","author":"Bhatia","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0650","first-page":"695","article-title":"Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence","volume":"91","author":"Bianchi Porro","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0655","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2036.1997.00173.x","article-title":"Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori","volume":"11","author":"Breuer","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2017.01.002_bib0660","first-page":"335","article-title":"Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection","volume":"35","author":"Figura","year":"2012","journal-title":"New Microbiol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570517300092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570517300092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T16:10:56Z","timestamp":1719072656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570517300092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0210570517300092"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2017.01.002","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An optimized clarithromycin-free 14-day triple therapy for Helicobacter pylori eradication achieves high cure rates in Uruguay","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U., AEEH y AEG. All rights reserved.","name":"copyright","label":"Copyright"}]}}